Clinical Trial - Trial ChiCTR2100049744
Access comprehensive clinical trial information for ChiCTR2100049744 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Sichuan Provincial Center for Disease Control and Prevention and is currently Completed. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100049744
Phase 1/2
Completed
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100049744
View on Chinese Clinical Trial Registry
Untitled Trial
A randomized, double blind and placebo controlled phase I/II clinical trial to explore the safety and immunogenicity of the COVID 19 DNA vaccine used as a boost dose to subjects previously immunized with COVID 19 inactivated vaccines
Study Focus
Sponsor & Location
Sichuan Provincial Center for Disease Control and Prevention
sponsor
China
Timeline & Enrollment
Phase 1/2
N/A
Jan 15, 2023
ICD-10 Classifications
COVID-19, virus identified
Viral pneumonia, unspecified
Other viral pneumonia
COVID-19, virus not identified
Pneumonia in viral diseases classified elsewhere
Data Source
Chinese Clinical Trial Registry
ChiCTR2100049744
Non-Device Trial